JavaScript is disabled for your browser. Some features of this site may not work without it.
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

PAHO IRISWPRO IRIS

A guide to introducing a second dose of measles vaccine into routine immunization schedules

Thumbnail
View/Open
WHO_IVB_13.03_eng.pdf (‎1.828Mb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
Other Titles
Guide pour l'introduction d'une deuxième dose de vaccin antirougeoleux (‎WR2)‎ dans les calendriers de vaccination de routine
Citation
World Health Organization. (‎2013)‎. A guide to introducing a second dose of measles vaccine into routine immunization schedules. World Health Organization. http://www.who.int/iris/handle/10665/85900
Description
59 p.
Gov't Doc #
WHO/IVB/13.03
Other Language Versions
français
Collections
  • Technical Documents
Language
English
français
Metadata
Show full item record

Related items

Showing items related by title and MeSH subject.

  • Thumbnail

    Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines : randomized trials in Mexican schoolchildren / John V. Bennett ... [‎et al.]‎ 

    Bennett, John V; Fernandez de Castro, Jorge; Valdespino-Gomez, Jose Luis; Garcia-Garcia, Ma de Lourdes ?UNAUTHORIZED; Islas-Romero, Rocio; Echaniz-Aviles, Gabriela; Jimenez-Corona, Aida; Sepulveda-Amor, Jaime (‎2002)‎
  • Thumbnail

    Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran 

    Izadi, S.; Azad, T.Mokhtari; Zahraei, S.M. (‎2015)‎
    كثيراً ما توجد تباينات بين تغطية التطعيم المسجلة وبين المستوى الحقيقي للمناعة في المجتمع. ولتقدير تغطية التلقيح ضد الحصبة في جنوب شرق جمهورية إيران الإسلامية تم إجراء دراسة مقطعية في 3 مناطق خلال صيف عام 2011.فتم اختيار عينة عنقودية من 1368 طفلاً تتراوح أعمارهم ما بين 30-54 شهراً باستخدام الاحتمال المتناسب مع الحجم. وتم فحص عينات مصلية من 663 منهم - ممن تلقوا حقنتين من اللقاح الثلاثي ضد الحصبة والنكاف والحصبة الألمانية [‎MMR]‎- للتأكد من وجود الجلوبيولين المناعي G [‎IgG]‎المضاد للحصبة. لقد بلغت تغطية التطعيم بالجرعة الثانية من لقاح MMR 93.7%.وكان ...
  • Thumbnail

    Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh / Syed M. Akramuzzaman ... [‎et al.]‎ 

    Akramuzzaman, Syed M; Cutts, Felicity T; Hossain, Md J; Wahedi, Obaidullah K; Nahar, Nazmun; Islam, Darul; Shaha, Narayan C; Mahalanabis, Dilip (‎2002)‎

Show Statistical Information

View Item 
  • IRIS Home
  • 1. Headquarters
  • Technical Documents
  • View Item
  • IRIS Home
  • 1. Headquarters
  • Technical Documents
  • View Item

© WHO 2017

Quick Links

Sitemap

  • Home
  • Health topics
  • Data
  • Media centre
  • Publications
  • Countries
  • Programmes and projects
  • Governance
  • About WHO

Help and Services

  • Contacts
  • FAQs
  • Employment
  • Feedback
  • Privacy
  • E-mail scams

WHO Regional Offices

  • WHO African Region
  • WHO Region of the Americas
  • WHO South-East Asia Region
  • WHO European Region
  • WHO Eastern Mediterranean Region
  • WHO Western Pacific Region